The levels of AFP, CEA, TBIL, AST, ALT, ALP, γ-GT, LDH, 5’-NT, AFU, WBC and monocyte in HCC patients were significantly higher than those in patients with CHB and/or healthy group (p < 0.001). This evidence concerns the gene CEACAM5 and hepatocellular carcinoma.